These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16254492)

  • 1. Structure and stability of internodal myelin in mouse models of hereditary neuropathy.
    Avila RL; Inouye H; Baek RC; Yin X; Trapp BD; Feltri ML; Wrabetz L; Kirschner DA
    J Neuropathol Exp Neurol; 2005 Nov; 64(11):976-90. PubMed ID: 16254492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy.
    Gilardini A; Avila RL; Oggioni N; Rodriguez-Menendez V; Bossi M; Canta A; Cavaletti G; Kirschner DA
    Neurotoxicology; 2012 Jan; 33(1):1-7. PubMed ID: 22079976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P0 (protein zero) mutation S34C underlies instability of internodal myelin in S63C mice.
    Avila RL; D'Antonio M; Bachi A; Inouye H; Feltri ML; Wrabetz L; Kirschner DA
    J Biol Chem; 2010 Dec; 285(53):42001-12. PubMed ID: 20937820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking.
    Patzig J; Kusch K; Fledrich R; Eichel MA; Lüders KA; Möbius W; Sereda MW; Nave KA; Martini R; Werner HB
    Glia; 2016 Jan; 64(1):155-74. PubMed ID: 26393339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of immune cells in animal models for inherited peripheral neuropathies.
    Wang Ip C; Kroner A; Fischer S; Berghoff M; Kobsar I; Mäurer M; Martini R
    Neuromolecular Med; 2006; 8(1-2):175-90. PubMed ID: 16775375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies.
    Martini R; Zielasek J; Toyka KV; Giese KP; Schachner M
    Nat Genet; 1995 Nov; 11(3):281-6. PubMed ID: 7581451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice.
    Wrabetz L; D'Antonio M; Pennuto M; Dati G; Tinelli E; Fratta P; Previtali S; Imperiale D; Zielasek J; Toyka K; Avila RL; Kirschner DA; Messing A; Feltri ML; Quattrini A
    J Neurosci; 2006 Feb; 26(8):2358-68. PubMed ID: 16495463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuregulin 1-erbB signaling is necessary for normal myelination and sensory function.
    Chen S; Velardez MO; Warot X; Yu ZX; Miller SJ; Cros D; Corfas G
    J Neurosci; 2006 Mar; 26(12):3079-86. PubMed ID: 16554459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder.
    Rünker AE; Kobsar I; Fink T; Loers G; Tilling T; Putthoff P; Wessig C; Martini R; Schachner M
    J Cell Biol; 2004 May; 165(4):565-73. PubMed ID: 15148307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective gene transfer of lacZ and P0 into Schwann cells of P0-deficient mice.
    Guénard V; Schweitzer B; Flechsig E; Hemmi S; Martini R; Suter U; Schachner M
    Glia; 1999 Jan; 25(2):165-78. PubMed ID: 9890631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charcot-Marie-Tooth disease and related inherited neuropathies.
    Murakami T; Garcia CA; Reiter LT; Lupski JR
    Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perk Ablation Ameliorates Myelination in S63del-Charcot-Marie-Tooth 1B Neuropathy.
    Musner N; Sidoli M; Zambroni D; Del Carro U; Ungaro D; D'Antonio M; Feltri ML; Wrabetz L
    ASN Neuro; 2016; 8(2):. PubMed ID: 27095827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in demyelinating peripheral neuropathies support molecular model of myelin P0-glycoprotein extracellular domain.
    Kirschner DA; Saavedra RA
    J Neurosci Res; 1994 Sep; 39(1):63-9. PubMed ID: 7528817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.
    Anderson TD; Davidovich A; Feldman D; Sprinkle TJ; Arezzo J; Brosnan C; Calderon RO; Fossom LH; DeVries JT; DeVries GH
    Lab Invest; 1994 May; 70(5):724-39. PubMed ID: 7515130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited demyelinating peripheral neuropathies: relating myelin packing abnormalities to P0 molecular defects.
    Kirschner DA; Szumowski K; Gabreëls-Festen AA; Hoogendijk JE; Bolhuis PA
    J Neurosci Res; 1996 Nov; 46(4):502-8. PubMed ID: 8950710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolipid protein cannot replace P0 protein as the major structural protein of peripheral nervous system myelin.
    Yin X; Kiryu-Seo S; Kidd GJ; Feltri ML; Wrabetz L; Trapp BD
    Glia; 2015 Jan; 63(1):66-77. PubMed ID: 25066805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schwann cells ER-associated degradation contributes to myelin maintenance in adult nerves and limits demyelination in CMT1B mice.
    Volpi VG; Ferri C; Fregno I; Del Carro U; Bianchi F; Scapin C; Pettinato E; Solda T; Feltri ML; Molinari M; Wrabetz L; D'Antonio M
    PLoS Genet; 2019 Apr; 15(4):e1008069. PubMed ID: 30995221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene dosage effects in hereditary peripheral neuropathy. Expression of peripheral myelin protein 22 in Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies.
    Gabriel JM; Erne B; Pareyson D; Sghirlanzoni A; Taroni F; Steck AJ
    Neurology; 1997 Dec; 49(6):1635-40. PubMed ID: 9409359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathy-related mutations alter the membrane binding properties of the human myelin protein P0 cytoplasmic tail.
    Raasakka A; Ruskamo S; Barker R; Krokengen OC; Vatne GH; Kristiansen CK; Hallin EI; Skoda MWA; Bergmann U; Wacklin-Knecht H; Jones NC; Hoffmann SV; Kursula P
    PLoS One; 2019; 14(6):e0216833. PubMed ID: 31173589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.
    Niemann A; Berger P; Suter U
    Neuromolecular Med; 2006; 8(1-2):217-42. PubMed ID: 16775378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.